NervGen Pharma Corp (NGEN) Straddle

Trading a NGEN straddle lets you take a pure volatility position on NervGen Pharma Corp without committing to a direction. NervGen Pharma Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NGEN straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on NGEN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when NervGen Pharma Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NGEN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the NGEN straddle is the cleanest expression of that view. Our scanner prices every NGEN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NGEN straddle into a catalyst or short a NGEN straddle to harvest decay, the options straddle setups that matter are all in one place.